Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ralimetinib (LY 2228820)
i
Other names:
LSN-2322600, LY-2228820, LY 2228820, LY2228820
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Eli Lilly
Drug class:
MAPK inhibitor, p38 inhibitor
Related drugs:
‹
chidamide (23)
SB202190 (1)
VT-11CR (0)
RG7842 (0)
UM-164 (0)
ARRY-614 (0)
chidamide (23)
SB202190 (1)
VT-11CR (0)
RG7842 (0)
UM-164 (0)
ARRY-614 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login